| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |